These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33639681)

  • 1. The Effect of Metformin on Survival Outcomes of Non-Metastatic Breast Cancer Patients with Type 2 Diabetes.
    Behrouzi B; Zokaasadi M; Mohagheghi MA; Emami AH; Sadighi S
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):611-616. PubMed ID: 33639681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of metformin on breast cancer outcomes in patients with type 2 diabetes.
    Oppong BA; Pharmer LA; Oskar S; Eaton A; Stempel M; Patil S; King TA
    Cancer Med; 2014 Aug; 3(4):1025-34. PubMed ID: 24944108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.
    Bayraktar S; Hernadez-Aya LF; Lei X; Meric-Bernstam F; Litton JK; Hsu L; Hortobagyi GN; Gonzalez-Angulo AM
    Cancer; 2012 Mar; 118(5):1202-11. PubMed ID: 21800293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer.
    Xiao Y; Zhang S; Hou G; Zhang X; Hao X; Zhang J
    Tumour Biol; 2014 Mar; 35(3):2035-45. PubMed ID: 24096546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.
    He X; Esteva FJ; Ensor J; Hortobagyi GN; Lee MH; Yeung SC
    Ann Oncol; 2012 Jul; 23(7):1771-80. PubMed ID: 22112968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus.
    Hui T; Shang C; Yang L; Wang M; Li R; Song Z
    Sci Rep; 2021 May; 11(1):10034. PubMed ID: 33976288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
    Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
    Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2.
    Lee SH; Yoon SH; Lee HS; Chung MJ; Park JY; Park SW; Song SY; Chung JB; Bang S
    Dig Liver Dis; 2016 Apr; 48(4):435-40. PubMed ID: 26775128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin and survival in diabetic patients with breast cancer.
    El-Benhawy SA; El-Sheredy HG
    J Egypt Public Health Assoc; 2014 Dec; 89(3):148-53. PubMed ID: 25534180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy.
    Wink KC; Belderbos JS; Dieleman EM; Rossi M; Rasch CR; Damhuis RA; Houben RM; Troost EG
    Radiother Oncol; 2016 Mar; 118(3):453-9. PubMed ID: 26861738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
    Lee KN; Torres MA; Troeschel AN; He J; Gogineni K; McCullough LE
    PLoS One; 2020; 15(5):e0232581. PubMed ID: 32369516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.
    He XX; Tu SM; Lee MH; Yeung SJ
    Ann Oncol; 2011 Dec; 22(12):2640-2645. PubMed ID: 21415239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes.
    Hou G; Zhang S; Zhang X; Wang P; Hao X; Zhang J
    Breast Cancer Res Treat; 2013 Feb; 137(3):807-16. PubMed ID: 23292119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
    Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
    Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do endometrial cancer patients benefit from metformin intake?
    Lemańska A; Zaborowski M; Spaczyński M; Nowak-Markwitz E
    Ginekol Pol; 2015 Jun; 86(6):419-23. PubMed ID: 26255448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
    Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
    Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes.
    Zhou J; Ke Y; Lei X; Wu T; Li Y; Bao T; Tang H; Zhang C; Wu X; Wang G; Li J; Zhang H; Ni F; Ye Z; Wang L
    Ann Hepatol; 2020; 19(3):320-328. PubMed ID: 31980358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes.
    Urpilainen E; Kangaskokko J; Puistola U; Karihtala P
    Tumour Biol; 2019 Jan; 41(1):1010428318815413. PubMed ID: 30803422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation.
    Chen TM; Lin CC; Huang PT; Wen CF
    J Gastroenterol Hepatol; 2011 May; 26(5):858-65. PubMed ID: 21251068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes.
    Tan BX; Yao WX; Ge J; Peng XC; Du XB; Zhang R; Yao B; Xie K; Li LH; Dong H; Gao F; Zhao F; Hou JM; Su JM; Liu JY
    Cancer; 2011 Nov; 117(22):5103-11. PubMed ID: 21523768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.